TW243445B - - Google Patents
Info
- Publication number
- TW243445B TW243445B TW083100396A TW83100396A TW243445B TW 243445 B TW243445 B TW 243445B TW 083100396 A TW083100396 A TW 083100396A TW 83100396 A TW83100396 A TW 83100396A TW 243445 B TW243445 B TW 243445B
- Authority
- TW
- Taiwan
- Prior art keywords
- pct
- sec
- date
- tumors
- pub
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US656993A | 1993-01-21 | 1993-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW243445B true TW243445B (zh) | 1995-03-21 |
Family
ID=21721516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW083100396A TW243445B (zh) | 1993-01-21 | 1994-01-18 |
Country Status (20)
Country | Link |
---|---|
US (1) | US5648365A (zh) |
EP (1) | EP0680470B1 (zh) |
JP (1) | JP3398748B2 (zh) |
KR (1) | KR100377280B1 (zh) |
AT (1) | ATE150748T1 (zh) |
AU (1) | AU679723B2 (zh) |
CA (1) | CA2152794C (zh) |
DE (1) | DE69309310T2 (zh) |
DK (1) | DK0680470T3 (zh) |
ES (1) | ES2102830T3 (zh) |
FI (1) | FI112474B (zh) |
GR (1) | GR3023188T3 (zh) |
HU (1) | HUT72078A (zh) |
IL (1) | IL108369A (zh) |
MX (1) | MX9400563A (zh) |
NO (1) | NO305166B1 (zh) |
NZ (1) | NZ261414A (zh) |
TW (1) | TW243445B (zh) |
WO (1) | WO1994017040A1 (zh) |
ZA (1) | ZA94317B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0643693T3 (da) * | 1992-02-06 | 1999-11-29 | Merrell Pharma Inc | Reversering af multi-lægemiddelresistens med triphenyl-piperidin-derivater |
WO2001007034A1 (en) * | 1999-07-23 | 2001-02-01 | Colorado State University Research Foundation | Multidrug resistance pump inhibitors and uses thereof |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
US20030109448A1 (en) * | 2001-11-07 | 2003-06-12 | Crowley Kathleen S. | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
KR100656490B1 (ko) * | 2001-11-26 | 2006-12-12 | 삼성에스디아이 주식회사 | 풀칼라 유기전계 발광표시소자 및 그의 제조방법 |
US8153184B2 (en) * | 2001-11-26 | 2012-04-10 | Samsung Mobile Display Co., Ltd. | Organic EL display device and method of manufacturing the same |
PT2956440T (pt) | 2013-02-08 | 2018-05-08 | Gen Mills Inc | Produtos alimentares com baixo teor de sódio |
CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
US4035372A (en) * | 1976-08-13 | 1977-07-12 | G. D. Searle & Co. | 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines |
EP0228893A3 (en) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US4990511A (en) * | 1988-08-03 | 1991-02-05 | Takeda Chemical Industries, Ltd. | Amide compounds, their production and use |
HUT59377A (en) * | 1989-06-19 | 1992-05-28 | Wellcome Found | Process for producing drugs containing new aromatic rings |
GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
ATE162797T1 (de) * | 1990-08-14 | 1998-02-15 | Roussel Uclaf | Neue 19-nor steroide, die eine amid tragende gruppe in der 11-beta-stelle haben, ihre herstellung, ihre verwendung als medikamente und pharmazeutische präparate davon |
DK0643693T3 (da) * | 1992-02-06 | 1999-11-29 | Merrell Pharma Inc | Reversering af multi-lægemiddelresistens med triphenyl-piperidin-derivater |
-
1993
- 1993-12-17 JP JP51701194A patent/JP3398748B2/ja not_active Expired - Fee Related
- 1993-12-17 KR KR1019950702950A patent/KR100377280B1/ko not_active IP Right Cessation
- 1993-12-17 EP EP94906446A patent/EP0680470B1/en not_active Expired - Lifetime
- 1993-12-17 DK DK94906446.3T patent/DK0680470T3/da active
- 1993-12-17 AT AT94906446T patent/ATE150748T1/de not_active IP Right Cessation
- 1993-12-17 AU AU60148/94A patent/AU679723B2/en not_active Ceased
- 1993-12-17 DE DE69309310T patent/DE69309310T2/de not_active Expired - Fee Related
- 1993-12-17 WO PCT/US1993/012300 patent/WO1994017040A1/en active IP Right Grant
- 1993-12-17 HU HU9502195A patent/HUT72078A/hu unknown
- 1993-12-17 ES ES94906446T patent/ES2102830T3/es not_active Expired - Lifetime
- 1993-12-17 NZ NZ261414A patent/NZ261414A/en unknown
- 1993-12-17 US US08/481,538 patent/US5648365A/en not_active Expired - Fee Related
- 1993-12-17 CA CA002152794A patent/CA2152794C/en not_active Expired - Fee Related
-
1994
- 1994-01-17 ZA ZA94317A patent/ZA94317B/xx unknown
- 1994-01-18 TW TW083100396A patent/TW243445B/zh active
- 1994-01-19 IL IL10836994A patent/IL108369A/en not_active IP Right Cessation
- 1994-01-20 MX MX9400563A patent/MX9400563A/es not_active IP Right Cessation
-
1995
- 1995-07-20 FI FI953506A patent/FI112474B/fi active
- 1995-07-20 NO NO952885A patent/NO305166B1/no not_active IP Right Cessation
-
1997
- 1997-04-21 GR GR970400848T patent/GR3023188T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX9400563A (es) | 1994-07-29 |
AU679723B2 (en) | 1997-07-10 |
CA2152794A1 (en) | 1994-08-04 |
IL108369A (en) | 1999-08-17 |
DE69309310D1 (de) | 1997-04-30 |
DE69309310T2 (de) | 1997-11-06 |
NO952885D0 (no) | 1995-07-20 |
WO1994017040A1 (en) | 1994-08-04 |
EP0680470B1 (en) | 1997-03-26 |
ES2102830T3 (es) | 1997-08-01 |
AU6014894A (en) | 1994-08-15 |
KR960700230A (ko) | 1996-01-19 |
ZA94317B (en) | 1994-08-18 |
ATE150748T1 (de) | 1997-04-15 |
HU9502195D0 (en) | 1995-09-28 |
JPH08505870A (ja) | 1996-06-25 |
FI112474B (fi) | 2003-12-15 |
HUT72078A (en) | 1996-03-28 |
NO305166B1 (no) | 1999-04-12 |
DK0680470T3 (zh) | 1997-04-28 |
GR3023188T3 (en) | 1997-07-30 |
IL108369A0 (en) | 1994-04-12 |
FI953506A (fi) | 1995-07-20 |
NZ261414A (en) | 1997-06-24 |
NO952885L (no) | 1995-09-20 |
FI953506A0 (fi) | 1995-07-20 |
CA2152794C (en) | 1999-04-06 |
US5648365A (en) | 1997-07-15 |
EP0680470A1 (en) | 1995-11-08 |
JP3398748B2 (ja) | 2003-04-21 |
KR100377280B1 (ko) | 2003-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5454894A (en) | Pyrazoles having CRF antagonist activity | |
TW285667B (zh) | ||
AU6787496A (en) | Use of phenol substituted diphosphonates as antineoplastic agents | |
AU6039194A (en) | Imidazopyridines and their use in treating gastrointestinal diseases | |
DK0680470T3 (zh) | ||
AU2797695A (en) | Thiazolidine derivatives, their preparation and drugs containing same | |
TW226330B (zh) | ||
AU3809095A (en) | 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives | |
DK0477141T3 (zh) | ||
IL104049A0 (en) | 7'-amino-naphthazarin antibiotic derivatives | |
DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet | |
MX9705378A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad. |